Related Experiment Video
Updated: May 28, 2025
10:11
Author Spotlight: Investigating the Motion Dynamics of the Eukaryotic Replisome Components at the Single-Molecule Level
Published on: July 26, 2024
926
Utilization of DNA Replication factor MCM2 by Cancer
Yuwei Yuan1, Tian Zeng1, Anbo Gao2
1Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Current Cancer Drug Targets
|February 14, 2025
Summary
Microchromosome maintenance 2 (MCM2) is crucial for DNA replication and cell cycle regulation. Aberrant MCM2 expression is linked to various cancers, suggesting its potential as a diagnostic biomarker and therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Microchromosome maintenance 2 (MCM2) is a key protein in the MCM family, essential for DNA replication initiation and cell cycle progression.
- Abnormal MCM2 expression is frequently observed across numerous cancer types, including breast, lung, and prostate cancers.
- This dysregulation is associated with critical aspects of tumorigenesis, such as tumor growth, invasion, and metastasis.
Purpose of the Study:
- To review the protein structure, physiological functions, and oncogenic mechanisms of MCM2.
- To highlight MCM2's role in various cancers and its potential as a biomarker.
- To explore MCM2 as a therapeutic target for cancer treatment.
Main Methods:
- Literature review of scientific publications.
- Analysis of existing data on MCM2 expression in different cancer types.
- Synthesis of information regarding MCM2's structure, function, and involvement in carcinogenesis.
Main Results:
- MCM2 plays a vital role in DNA replication and maintaining cellular cycle stability.
- Elevated MCM2 levels correlate with tumorigenesis, invasion, migration, and poor prognosis in multiple cancers.
- MCM2 is implicated in breast, cervical, ovarian, lung, hepatocellular, nephroblastoma, prostate, and pancreatic cancers.
Conclusions:
- MCM2 is a significant biomarker for early cancer detection, diagnosis, and prognosis.
- Targeting MCM2 presents a promising strategy for developing novel cancer therapies.
- Further research into MCM2's mechanisms can advance cancer management.
More Related Videos
Related Concept Videos
02:37Restarting Stalled Replication Forks
5.7K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.7K
02:38S-Cdk Initiates DNA Replication
4.6K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
4.6K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:37DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
01:20Mismatch Repair
4.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.7K
00:55DNA Helicases
21.1K
DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
21.1K